AstraZeneca (AZN) reported its Q2 2026 financial results on July 27, 2026, before the market open. The company reported earnings per share (EPS) of 1.99 GBP, beating the analyst estimate of 1.87 GBP by 6.2%. Revenue for the quarter reached 11636 million GBP. Following the publication, the stock price rose by 1.72%.
Generated automatically from our data — as of August 6, 2026
Key figures at a glance
Estimate (EPS): 1.87 GBP
Reported (EPS): 1.99 GBP
Price reaction: +1.7%
Frequently asked questions
Did AstraZeneca beat or miss earnings-per-share expectations?
AstraZeneca beat the analyst estimate of 1.87 GBP earnings per share (Q2 2026) by 6.2%, reporting 1.99 GBP.
How did AstraZeneca stock react to the earnings report?
AstraZeneca stock rose 1.7% on the trading day following the release.
What was AstraZeneca's revenue in Q2 2026?
AstraZeneca reported revenue of 11,636M GBP in Q2 2026.